Dr. Leichman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1180 N Indian Canyon Dr
Ste E218
Palm Springs, CA 92262Phone+1 760-416-4860Fax+1 760-416-4903
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1977 - 1979
Wayne State University School of MedicineResidency, Internal Medicine, 1975 - 1977- Detroit Medical Center/Wayne State UniversityInternship, Internal Medicine, 1973 - 1974
- Wayne State University School of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1987 - 2025
NY State Medical License 1997 - 2025
MI State Medical License Active through 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma Start of enrollment: 1994 Aug 01
- Altretamine and Etoposide in Treating Patients With HIV-Related Cancer Start of enrollment: 1996 Jul 01
- Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma Start of enrollment: 1996 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOmission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study.Chengwei Peng, Saad Saffo, Paul E Oberstein, Michael Shusterman, Charlene Thomas
Journal of the National Comprehensive Cancer Network. 2024-09-05 - 57 citationsTrastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo
The Lancet. Oncology. 2022-02-01 - Going Back.Lawrence Leichman
The Oncologist. 2021-01-01
Journal Articles
- Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction and Gastric AdenocarcinomaLawrence Leichman, Jason K Sicklick, Shumei Kato, Kaitlyn Kelly, Scott M Lippman, Clinical Cancer Research
Grant Support
- Response Determinants In Esophageal And Gastric CancersNational Cancer Institute1994–1995
- Thymidylate Synthase Quantitation In Human Colon CancerNational Cancer Institute1993–1995
- Response Determinants In Egophageal And Gastric CancersNational Cancer Institute1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
